(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

CÉLULAS CAR-T ANTI-BCMA PARA DEPLEÇÃO DE CÉLULAS PLASMÁTICAS

ArquivadaInvention PatentPCT · US2019029503

Application data

Number

112020021894

Type

Invention Patent

Filing

04/26/2019

Publication

03/09/2021

PCT

US2019029503

Progress at the INPI

  1. Filing04/26/19
  2. Publication03/09/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 04/26/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 10/25/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

BAYER HEALTHCARE LLC

US

CRISPR THERAPEUTICS AG

CH

See this company's full portfolio

Inventors

G. C. (pessoa física)

US

Technical data

Priority claims

US

62/663,974 · 04/27/2018

US

62/773,058 · 11/29/2018

Abstract

CÉLULAS CAR-T ANTI-BCMA PARA DEPLEÇÃO DE CÉLULAS PLASMÁTICAS. A presente invenção refere-se a composições e métodos para a depleção controlada de células plasmáticas, tal como para o tratamento de várias doenças e condições associadas às células plasmáticas.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

10/25/2022

RPI 2703

Arquivamento - Art. 33 da LPI

#11.1

08/09/2022

RPI 2692

Adição na publicação

#15.35

12/14/2021

RPI 2658

Notificação de entrada na fase nacional - PCT

#1.3

03/09/2021

RPI 2618

Alteração de dados cadastrais

#1.1

11/03/2020

RPI 2600

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.